Published in J Bras Pneumol on January 04, 2013
Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry (2009) 4.66
A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol (2004) 4.24
Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health (2004) 3.71
Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial. J Natl Cancer Inst (2004) 3.26
A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet (2008) 3.25
Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res (2006) 2.77
Prevalence and predictors of transitions in smoking behavior among college students. Health Psychol (2004) 2.64
Have we lost our way? The need for dynamic formulations of smoking relapse proneness. Addiction (2002) 2.48
The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med (2011) 2.43
Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol (2006) 2.30
Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol (2002) 2.18
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry (2012) 2.02
Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention. Nicotine Tob Res (2006) 2.02
Clinical practice. Treating smokers in the health care setting. N Engl J Med (2011) 1.99
Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med (2009) 1.95
Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol (2008) 1.86
Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol (2003) 1.79
Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J Abnorm Psychol (2008) 1.72
A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. Nicotine Tob Res (2008) 1.70
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol (2003) 1.64
Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res (2010) 1.63
Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res (2008) 1.62
Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol (2010) 1.61
Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol (2010) 1.60
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction (2010) 1.60
Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl) (2011) 1.60
Using the Saint George's Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: validating a new version for use in Brazil. J Bras Pneumol (2007) 1.59
Smoking-cessation media campaigns and their effectiveness among socioeconomically advantaged and disadvantaged populations. Am J Public Health (2008) 1.57
A pilot study on mindfulness based stress reduction for smokers. BMC Complement Altern Med (2007) 1.55
Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction (2008) 1.53
Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers. Ann Behav Med (2012) 1.52
Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J (2011) 1.50
Smoker characteristics and smoking-cessation milestones. Am J Prev Med (2011) 1.47
Educational camp for children with asthma. J Bras Pneumol (2008) 1.46
Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. JAMA Psychiatry (2013) 1.38
Efficacy of bupropion alone and in combination with nicotine gum. Nicotine Tob Res (2007) 1.33
Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol (2011) 1.33
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Exp Clin Psychopharmacol (2003) 1.33
Progression of college-age cigarette samplers: what influences outcome. Addict Behav (2005) 1.32
Interventions for tobacco smoking. Annu Rev Clin Psychol (2013) 1.32
Organization, financing, promotion, and cost of U.S. quitlines, 2004. Am J Prev Med (2006) 1.30
Integrating smoking cessation treatment into primary care: an effectiveness study. Prev Med (2004) 1.28
Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking. Nicotine Tob Res (2005) 1.27
Alcohol consumption, smoking urge, and the reinforcing effects of cigarettes: an ecological study. Psychol Addict Behav (2008) 1.26
Effective tobacco dependence treatment. JAMA (2002) 1.25
Smoke, the chief killer--strategies for targeting combustible tobacco use. N Engl J Med (2014) 1.24
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet Genomics (2013) 1.24
The Wisconsin Predicting Patients' Relapse questionnaire. Nicotine Tob Res (2009) 1.20
The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. J Consult Clin Psychol (2011) 1.20
Smoking intensity and lipoprotein abnormalities in active smokers. J Clin Lipidol (2009) 1.19
Smoking cessation in smokers who smoke menthol and non-menthol cigarettes. Addiction (2014) 1.18
Effectiveness of a clinic-based strategy for implementing the AHRQ Smoking Cessation Guideline in primary care. Prev Med (2002) 1.18
Depression predicts smoking early but not late in a quit attempt. Nicotine Tob Res (2007) 1.17
An fMRI investigation of the impact of withdrawal on regional brain activity during nicotine anticipation. Psychophysiology (2009) 1.15
Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt. Ann Behav Med (2012) 1.12
Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. Am Heart J (2010) 1.10
Dissection of the phenotypic and genotypic associations with nicotinic dependence. Nicotine Tob Res (2011) 1.09
Use of the vital sign stamp as a systematic screening tool to promote smoking cessation. Mayo Clin Proc (2003) 1.08
Do state characteristics matter? State level factors related to tobacco cessation quitlines. Tob Control (2007) 1.07
Implementing guidelines for smoking cessation: comparing the efforts of nurses and medical assistants. Am J Prev Med (2004) 1.06
Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives: II. Evidence from a laboratory self-administration assay. J Abnorm Psychol (2010) 1.06
Fax referrals, academic detailing, and tobacco quitline use: a randomized trial. Am J Prev Med (2012) 1.06
A multi-level analysis of non-significant counseling effects in a randomized smoking cessation trial. Addiction (2010) 1.03
Tobacco Dependence: Insights from Investigations of Self-Reported Smoking Motives. Curr Dir Psychol Sci (2010) 1.02
Incidence and risk factors for postoperative pulmonary complications in elective intracranial surgery. J Neurosurg (2008) 1.02
Critical issues in eHealth research. Am J Prev Med (2007) 1.02
Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine Tob Res (2003) 1.02
Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil. Cad Saude Publica (2005) 1.01
WISDM primary and secondary dependence motives: associations with self-monitored motives for smoking in two college samples. Drug Alcohol Depend (2010) 1.00
Healthcare costs around the time of smoking cessation. Am J Prev Med (2012) 0.99
Stealing a march in the 21st century: accelerating progress in the 100-year war against tobacco addiction in the United States. Am J Public Health (2009) 0.99
Relations of alcohol consumption with smoking cessation milestones and tobacco dependence. J Consult Clin Psychol (2012) 0.98
The Brazilian Portuguese version of the London Chest Activity of Daily Living scale for use in patients with chronic obstructive pulmonary disease. J Bras Pneumol (2008) 0.98
Tobacco cessation quitline spending in 2005 and 2006: what state-level factors matter? Int J Environ Res Public Health (2009) 0.98
Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones. Psychol Addict Behav (2012) 0.98
Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res (2011) 0.96
Long-term effects of smoking and smoking cessation on exercise stress testing: three-year outcomes from a randomized clinical trial. Am Heart J (2011) 0.95
Obesity and smoking: comparing cessation treatment seekers with the general smoking population. Obesity (Silver Spring) (2009) 0.95
Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide. Ann Am Thorac Soc (2014) 0.94
Randomized trial on mindfulness training for smokers targeted to a disadvantaged population. Subst Use Misuse (2014) 0.94
An Ecological Momentary Assessment analysis of relations among coping, affect and smoking during a quit attempt. Addiction (2010) 0.93
Barriers to effective tobacco-dependence treatment for the very poor. J Stud Alcohol Drugs (2012) 0.92
Using decision tree analysis to identify risk factors for relapse to smoking. Subst Use Misuse (2010) 0.92
Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures. Psychol Assess (2009) 0.92
Interactivity and Presence of Three eHealth Interventions. Comput Human Behav (2010) 0.91
Electronic health records as a tool for recruitment of participants' clinical effectiveness research: lessons learned from tobacco cessation. Transl Behav Med (2013) 0.90
Level of asthma control and its impact on activities of daily living in asthma patients in Brazil. J Bras Pneumol (2013) 0.90
Recruiting and engaging smokers in treatment in a primary care setting: developing a chronic care model implemented through a modified electronic health record. Transl Behav Med (2013) 0.90
An ecological momentary assessment analysis of prequit markers for smoking-cessation failure. Exp Clin Psychopharmacol (2012) 0.89
Risk factors for subclinical carotid atherosclerosis among current smokers. Prev Cardiol (2010) 0.87
Quality of life and physical limitations in primary brain tumor patients. Qual Life Res (2011) 0.86
Changes in tobacco quitlines in the United States, 2005-2006. Prev Chronic Dis (2010) 0.86
Early lapses in a cessation attempt: lapse contexts, cessation success, and predictors of early lapse. Nicotine Tob Res (2013) 0.86
Analysis and validation of probabilistic models for predicting malignancy in solitary pulmonary nodules in a population in Brazil. J Bras Pneumol (2012) 0.86
Pulmonary changes on HRCT scans in nonsmoking females with COPD due to wood smoke exposure. J Bras Pneumol (2013) 0.86
Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study. Chest (2007) 0.86
Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms. Hum Mol Genet (2013) 0.86